Similarly, genetic variations in the GCKR expression can also regulate glucose metabolism and insulin sensitivity in obesity-associated metabolic disorders including NAFLD and T2DM [5, 6]. The gene discussed is GCKR; the disease is obesity due to melanocortin 4 receptor deficiency.